Stocks in India are expected to stabilize after a significant drop, with Nifty futures showing a slight increase. Despite record equity investments in real estate, analysts warn of potential future earnings issues for developers. Kotak Securities highlights the risk of overvalued 'narrative stocks,' while further losses for the rupee are anticipated due to a less active RBI.
Related news
Analysts predict that reciprocal tariffs starting April 2 may impact equity markets, along with overseas market trends and FII activity. Investors will also focus on global developments, PMI data, rupee-dollar trends, and Brent crude prices. Given recent modest FII buying and quarterly earnings reports, potential tariffs could play a vital role in market movements.
Sebi has rejected Digvijay Gaekwad's application to make a competing offer for Religare Enterprises, citing insufficient proof of financial resources and non-compliance with a Supreme Court order. This clears the path for the Burmans, who are the largest shareholders, to gain control of the company.
Chinese electronics component makers are offering Indian companies price reductions up to 5% amid the US-China trade conflict and decreased American demand. This concession, driven by hefty US tariffs on Chinese goods, could boost Indian manufacturers' profits.
Foreign portfolio investors remain cautious on Indian equities in light of uncertainty around Q3 FY25 earnings recovery and fair market valuations, despite strong domestic institutional investor support. The Indian rupee's depreciation and global factors are contributing to market volatility.
The BJP-led Delhi government, under chief minister Rekha Gupta, is developing a new excise policy designed to boost revenue while ensuring transparency and avoiding societal issues. Drawing inspiration from successful excise policies in other states, the forthcoming policy aims to be "foolproof." This initiative follows the scrapping of the previous AAP government's excise policy due to corruption allegations.
Stocks rose on Wall Street as it deals with uncertainty caused by the ongoing trade war. The S&P 500, Dow Jones, and Nasdaq all showed gains. Investors are focusing on corporate news and awaiting updates on tariffs. Meanwhile, genetics testing company 23andMe took a significant hit, while The AZEK Co. surged on acquisition news.
The stock market is expected to undergo a significant shift with potential recovery soon, as highlighted by Morgan Stanley. Despite recent declines and low trading volumes, growth is anticipated to return, supported by government spending and positive retail investor participation.
Donald Trump's tariff threats have added volatility to global stock markets, significantly impacting India. Key sectors like automobiles, pharmaceuticals, textiles, and steel are at risk. Despite challenges, India's markets show resilience, and experts see current conditions as an investment opportunity. India's diplomatic approach could mitigate risks, aiming to attract foreign investments and reduce tariffs on US imports.
US stock and bond markets will close on Monday, January 20, 2025, for Martin Luther King Jr. Day, resuming normal operations on January 21.
PB Fintech's Policybazaar is investing Rs 860 crore for a 25% stake in PB Healthcare to develop hospitals with a 1,000-bed capacity. These hospitals aim to offer zero rejection and cashless treatment. The initiative seeks to address the rising healthcare costs and will initially cover the NCR before expanding further.